Robert S. Poulton

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.

Epicore BioNetworks, Inc. designs, develops, manufactures, and markets biotechnology products and specialty animal feeds. Its product lines are based on natural microbes and enzymes and have applications in aquaculture, agriculture and horticulture, cleaning and sanitation, food processing and nutrition, waste water, pollution control, and environmental remediation. The company was founded on January 9, 1987 and is headquartered in Eastampton, NJ.

Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.

Wyeth Ltd. (India) manufactures pharmaceutical drugs. The firm provides prescription pharmaceuticals, non-prescription consumer health care products and pharmaceuticals for animal health. The company was incorporated on September 20, 1947 and is headquartered in Mumbai, India.